ELHT Evidence Hub
  • HOME
  • FOCUS ON YOUR SPECIALTY OR PROFESSION
  • STUDY SKILLS
  • FICTION, LEISURE AND SELF-HELP

Prophylactic oxytocin is associated with an increased risk of postpartum haemorrhage compared to prophylactic oxytocin-ergometrine in active management of the third stage of labour

24/3/2017

0 Comments

 
Author(s): Brook A.; Martindale E.; Hamer F.; Choudhari Y.

Source: BJOG: An International Journal of Obstetrics and Gynaecology; Mar 2017; vol. 124 ; p. 55

Publication Date: Mar 2017

Publication Type(s): Conference Abstract

Abstract:Introduction Oxytocin (Syntocinon) may be associated with a rise in primary postpartum haemorrhage (PPH) compared with oxytocin-ergometrine (Syntometrine). The Royal College of Obstetricians and Gynaecologists has endorsed oxytocin as single agent in the active management of the third stage. We evaluated the local PPH incidence after vaginal delivery to coincide with a change in practice from oxytocin-ergometrine to oxytocin. Methods Data was extracted from an electronic record of deliveries. The change to 10 units IM oxytocin as third stage agent was introduced mid-August 2016. We scrutinized clinically significant PPH (>1000 ml) occurring both pre- and postintervention. Results 1414 vaginal deliveries occurred from June-October 2016. Median blood loss was 350 ml (50-4000). Overall, 99 cases of PPH occurred with median blood loss 1507 ml (1000-4000). PPH incidence at baseline was 7%, increasing to 9% in the 2 months after switchover. This would account for an additional 28 cases of PPH (>1000 ml) in the period and 168 additional cases per annum in our unit. Oxytocin was associated with a significant increase in PPH risk when compared to oxytocin-ergometrine (58/595 9.7% versus 39/549 7.1%; chi2 P = 0.03). Need for additional oxytocics increased following the change and was lower in those receiving syntometrine (14.7 versus 19.4%; chi2 P = 0.01). Multiple binary logistic regression revealed that choice of oxytocic was a significant determinant of PPH (B 0.636; P = 0.015). Conclusion Although national guidelines endorse oxytocin rather than oxytocin-ergometrine for an active third stage, local experience suggests a significant impact on PPH risk.
Database: EMBASE
0 Comments



Leave a Reply.

    The following databases were searched:
    EMBASE,  MEDLINE, PsycINFO, BNI, CINAHL, 
    to find  ELHT staff publications

    Specialties

    All
    ANAESTHETICS
    CARDIOLOGY
    CRITICAL CARE
    DERMATOLOGY
    DIABETES
    ELDERLY CARE
    EMERGENCY CARE
    GASTROENTEROLOGY
    GYNAECOLOGY
    JUNIOR DOCTORS
    MAXILLOFACIAL
    NEONATOLOGY
    NEUROLOGY
    NURSING
    OBSTETRICS
    ONCOLOGY
    OPHTHALMOLOGY
    ORTHOPAEDICS
    PAEDIATRICS
    PATHOLOGY
    PHYSIOTHERAPY
    RADIOLOGY
    RENAL
    RESPIRATORY
    RHEUMATOLOGY
    STROKE
    SURGERY
    UROLOGY
    VASCULAR SURGERY

    RSS Feed

    Archives - past 2 years

    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017

Picture
Contact us
Picture
Support
Picture
Feedback
Picture
Performance
Picture
Catalogue
Picture
News
Picture
OpenAthens
Picture
Search
Picture
Privacy Policy
Connect with us
Picture
Picture
Picture